QuantRx Biomedical Corporation

QTXB · OTC
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating Activities
Net Income-$260-$253-$622-$737
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$211$202$208$210
Other Non-Cash-$0-$25$222$269
Operating Cash Flow-$49-$75-$192-$258
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$201
Investing Cash Flow$0$0$0$201
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0-$20
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0-$101
Financing Cash Flow$0$0$0-$81
Forex Effect$0$0$0$0
Net Chg. in Cash-$49-$75-$192-$138
Supplemental Information
Beg. Cash$55$130$322$460
End Cash$6$55$130$322
Free Cash Flow-$49-$75-$192-$258
QuantRx Biomedical Corporation (QTXB) Financial Statements & Key Stats | AlphaPilot